artemether / lumefantrine

DRUG2 trials

Sponsors

Epicentre, PATH

Conditions

MalariaPlasmodium Falciparum

Phase 2

Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy

CompletedNCT04661579

PATHPlasmodium Falciparum

Start: 2020-11-06End: 2022-08-17Updated: 2024-07-19

Phase 4

Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy

CompletedNCT00495508

EpicentreMalaria

Start: 2006-10-31End: 2009-06-30Updated: 2022-06-03

Related Papers

Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic <i>Plasmodium falciparum</i>-Exposed, Drug-Treated Kenyan Adults

The Journal of Infectious Diseases2025-05-23

Timing of malaria in pregnancy and impact on infant growth and morbidity: a cohort study in Uganda.

2016-02-1632 citations

Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment.

2013-04-24104 citations

Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial.

2012-05-0321 citations

Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.

2010-11-0183 citations